Navigation Links
Shire Divests Non-Core Product Portfolio to Almirall
Date:10/8/2007

Reinforcing Strategic Focus on Growth-Driving Global Products

BASINGSTOKE, England, October 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces that it has agreed to sell a portfolio of non core products to Almirall for a cash consideration of $213m. The portfolio includes the dermatology products, SOLARAZE(R) (3% gel diclofenac sodium) and VANIQA(R) (eflornithine hydrochloride), and six other non-promoted products1 across a range of indications, which are principally sold by Shire in the UK, France, Germany, Italy, Spain and Ireland.

The divested products are no longer core to Shire's strategy of building market leading positions in specialty markets through the development and commercialization of competitive global products with strong intellectual property protection. Shire's focus is on building its attention deficit hyperactivity disorder (ADHD), human genetic therapies, gastrointestinal and renal diseases businesses and, with its recent in-licensing of JUVISTA(R) (human recombinant TGFβ3) from Renovo plc, Shire intends to build a new specialty area of regenerative medicine. Shire's specialty products are increasingly global in their reach - for example Shire aims to expand its ADHD expertise to markets outside the U.S. within the next two years, with an initial focus on the EU. This product divestment will enable Shire to pursue this strategy in a more concentrated way.

Shire plc Chief Executive, Matthew Emmens comments:

"Our strategic focus is clear and our emphasis in the international markets is on developing competitive positions for our global products that meet the needs of the specialist physicians and their patients, in our chosen areas of expertise. Almirall is well positioned to ensure future development and investment in the products we are divesting, which are no longer core to our strategy."

Almirall Chairman and CEO, Dr Jorg
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. A New C-Terminal GST Vector for Protein Production in S. pombe
2. Safe Production of High-Titer Retrovirus
3. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
4. Yeast Protein Production System Features High Yields and One-Step Purification
5. Identification of Differentially Expressed Gene Products with the CastAway System*
6. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
7. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
8. Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray Ion Trap Mass Spectrometry
9. Advantages of Roche Applied Science amplification products
10. Find the optimal product for your PCR application
11. Product overview

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ALTHAM, Mass., Nov. 19 Arlington M... that the leading driver of antibiotic selection i... activity against gram-positive and gram-negative ...n cause nosocomial pneumonia, surveyed European ph...s that provide appropriate coverage against common...
(Date:11/19/2009)... Top Gene Synthesis Companies Form International G... Practices in Risk Reduction ,Five Member Compan...is Capacity , (PRWEB) Nov...g gene synthesis companies today announced agreeme...l to promote biosecurity in the gene synthesis ind...
(Date:11/18/2009)...tute of Standards and Technology (NIST) has demons... detecting and measuring elusive hazards such as c... in food or pesticides distributed in soil by wind...than conventional techniques for detecting traces ...cules, having distinct electrically positive and n...
(Date:11/18/2009).... 18 Sangamo BioSciences...from the University of Pennsylvania investigator s...nger nuclease (ZFN) based product, SB-728-T, for H...ed on the internet. ,, Data were presented in a...School of Medicine from a single subject treated w...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
..., March 2 American Pacific Corporation (Nasdaq: ...ed subsidiary AMPAC Fine Chemicals LLC (AFC) recei...Award from the Department of Toxic Substances Cont... Council of California (CICC). The award recognize... AFC,s STRIDE (Sustainability Through Renewable In...
..., Pa., March 2 Morphotek(R), Inc., a subsidiary o...ced that it has commenced a,multi-centered Phase I...sothelioma. The study will evaluate MORAb-009, plu...m, as a first-line treatment for patients with,mes...y is to assess the efficacy of MORAb-009,as combin...
..., March 2 /PRNewswire-FirstCall/ - Angiotech Pharm... announced it has obtained a new Senior Secured Te... Foothill, LLC is the sole arranger, administrativ...lving Credit Facility. , The financing includes a ...10 million, and a secured revolving credit facilit...
Other Biology Technology:AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 2AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 3Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4
(Date:11/19/2009)... Leaf-cutter ants, which cultivate fungus for foo...ew one to add to the list: the ant farmers, like t... bacteria to make their gardens grow. The finding,...nce , documents a previously unknown symbiosis bet...ow leaf-cutter ants have come to dominate the Amer...
(Date:11/19/2009)...s an important crop in many countries of the world...feed, and industrial materials. It also is conside...cation, molecular evolution, and genome architectu...special collection used the first description of t...iguing questions in genetics and plant biology. Th...
(Date:11/19/2009)... Spring Harbor, NY A four-year, multi-institution...atory (CSHL) scientists culminated today in public...l Science revealing in unprecedented detail the ..., as it is commonly called by North American consu...and the most valuable agricultural crop grown in t...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 1HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 2Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
...may have found why women have an edge in keeping a... eat and excrete - at least before reaching menopa...r problems with salt-sensitive hypertension and hy...re essentially the same as men, says Dr. David Pol...enter at the Medical College of Georgia. , The re...
...9) Virginia Commonwealth University researchers h...in regulating mitochondria, the energy-producing m...d to the development of new treatments for heart d...to master the abnormal metabolism of cancer. , In...xpress, researchers reported that Stat3, a protein...
.... It occurs when changes take place in the genes t...h, cell signalling and blood vessel formation eit...ch as smoking or radiation or due to inherited ch...d environmental factors means that cancer is an ex...endometrial carcinoma, is no exception. , Cancer ...
Other Biology News:Researchers may have found why women have an edge on salt-sensitive hypertension 2New research findings may enable earlier diagnosis of uterine cancer 2
...teinChip arrays have been developed for affinity c...ety of ProteinChip chemical surfaces allow differe...e biochemical properties. Each chip has eight diff...on, and the chips are color-coded with a unique hy...
SmartSpec Printer Paper, 5 pack from Bio-Rad
...teinChip arrays have been developed for affinity c...ety of ProteinChip chemical surfaces allow differe...e biochemical properties. Each chip has eight diff...on, and the chips are color-coded with a unique hy...
...ssay with SR-101 Labeled Substrates (red fluoresce...re serine protease activation • No lysing, fi...Kits utilize cell-permeable, fluorescently labeled...e chymotrypsin-like activity in whole living cells...
Biology Products: